Certified by Founder Lodge
Actithera
Norway - Oslo
START UP
1 Disclosed Funding Rounds $75,500,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Actithera is a radiopharmaceutical biotech company translating medicinal chemistry insights into next-generation radioligand therapies (RLTs). Founded in 2021 by drug discovery innovator Dr.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 09 ,2025 | Series A | $75,500,000 |
Bioqube Ventures
4BIO Capital
Surveyor Capital
M Ventures(Netherlands)
Hadean Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
